K Blennow Selected Research

Cognitive Dysfunction

1/2023	Effect of a 1-Year Nutritional Blend Supplementation on Plasma p-tau181 and GFAP Levels among Community-Dwelling Older Adults: A Secondary Analysis of the Nolan Trial.
1/2018	Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease.
12/2014	The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.
1/2013	Open-heart surgery increases cerebrospinal fluid levels of Alzheimer-associated amyloid β.
2/2012	Age and diagnostic performance of Alzheimer disease CSF biomarkers.
10/2011	Predicting MCI outcome with clinically available MRI and CSF biomarkers.
1/2011	Progression from mild to pronounced MCI is not associated with cerebrospinal fluid biomarker deviations.
1/2010	Combination of hippocampal volume and cerebrospinal fluid biomarkers improves predictive value in mild cognitive impairment.
3/2009	Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment.
1/2008	Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K Blennow Research Topics

Disease

69	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2000
26	Dementia (Dementias) 01/2023 - 01/2000
20	Cognitive Dysfunction 01/2023 - 11/2000
9	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 03/2001
9	Atrophy 01/2017 - 01/2000
8	Amyloid Plaque 02/2012 - 01/2000
7	Frontotemporal Dementia (Semantic Dementia) 07/2008 - 01/2000
6	Normal Pressure Hydrocephalus 07/2023 - 07/2000
6	Inflammation (Inflammations) 07/2018 - 01/2001
5	Parkinson Disease (Parkinson's Disease) 01/2023 - 01/2000
5	Multiple Sclerosis 11/2020 - 04/2009
5	Necrosis 04/2018 - 06/2001
5	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 03/2010 - 07/2000
4	Brain Diseases (Brain Disorder) 12/2014 - 03/2001
4	Schizophrenia (Dementia Praecox) 07/2007 - 01/2000
3	Tauopathies 01/2019 - 05/2000
3	Mental Disorders (Mental Disorder) 04/2007 - 03/2001
2	Psychotic Disorders (Schizoaffective Disorder) 01/2019 - 05/2004
2	Neuroinflammatory Diseases 04/2018 - 04/2009
2	Parkinsonian Disorders (Parkinsonism) 01/2017 - 11/2015
2	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2008 - 11/2006
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2008 - 06/2000
2	Nervous System Diseases (Neurological Disorders) 01/2008 - 12/2007
1	Optic Neuritis (Retrobulbar Neuritis) 01/2021
1	Disease Progression 01/2021
1	Craniocerebral Trauma (Head Injury) 01/2019
1	Atrial Fibrillation 01/2019
1	Amyloidosis 12/2018
1	Guillain-Barre Syndrome 08/2018
1	Neoplasms (Cancer) 04/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2018
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Encephalitis (Encephalitis, Rasmussen) 01/2017
1	Autoimmune Diseases of the Nervous System 04/2016
1	Major Depressive Disorder (Major Depressive Disorders) 03/2016

Drug/Important Bio-Agent (IBA)

50	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2000
25	Amyloid (Amyloid Fibrils)IBA 01/2023 - 11/2000
24	Proteins (Proteins, Gene)FDA Link 07/2023 - 01/2000
17	Amyloid beta-PeptidesIBA 01/2023 - 11/2000
13	Apolipoproteins E (ApoE)IBA 01/2020 - 04/2000
11	tau Proteins (tau Protein)IBA 04/2016 - 11/2000
8	ApolipoproteinsIBA 01/2020 - 11/2000
6	CytokinesIBA 01/2013 - 11/2000
5	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2010 - 03/2001
4	Protein Isoforms (Isoforms)IBA 01/2020 - 07/2008
4	AlbuminsIBA 01/2019 - 01/2000
4	GAP-43 Protein (GAP 43 Protein)IBA 07/2018 - 01/2000
4	ButyrylcholinesteraseIBA 08/2011 - 06/2001
4	AcetylcholinesteraseIBA 08/2011 - 03/2001
4	Amino Acids FDA Link 07/2008 - 11/2000
3	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2000
3	Peptides (Polypeptides)IBA 01/2017 - 01/2008
3	Threonine (L-Threonine)FDA Link 10/2007 - 08/2002
3	Antipsychotic Agents (Antipsychotics)IBA 07/2007 - 01/2000
3	EsterasesIBA 01/2006 - 01/2001
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2004 - 09/2001
2	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 07/2023 - 08/2018
2	Serum AlbuminIBA 01/2019 - 04/2011
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 12/2014 - 01/2010
2	Apolipoprotein E4IBA 07/2014 - 01/2001
2	HomocysteineIBA 12/2013 - 05/2004
2	Neurofilament ProteinsIBA 04/2011 - 03/2007
2	CholesterolIBA 01/2011 - 01/2005
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2010 - 06/2001
2	AcidsIBA 04/2009 - 10/2001
2	neurofilament protein LIBA 12/2007 - 05/2000
2	Glucose (Dextrose)FDA LinkGeneric 02/2007 - 02/2003
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2006 - 01/2005
2	Kynurenic Acid (Kynurenate)IBA 12/2005 - 11/2001
2	Acetylcholine (Acetylcholine Chloride)FDA Link 09/2004 - 01/2001
2	Transforming Growth Factor beta (TGF-beta)IBA 08/2004 - 09/2003
2	InterleukinsIBA 08/2004 - 06/2001
2	CarbonIBA 05/2004 - 01/2001
2	amyloid beta-protein (1-42)IBA 03/2004 - 09/2002
2	Sulfoglycosphingolipids (Sulfatides)IBA 01/2004 - 07/2000
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2003 - 03/2001
2	Tacrine (Cognex)FDA Link 02/2003 - 01/2001
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 12/2002 - 01/2001
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2002 - 01/2001
2	Presenilin-1IBA 07/2001 - 06/2001
1	Protein AggregatesIBA 01/2023
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2021
1	EpitopesIBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	ChemokinesIBA 11/2020
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2019
1	NeurograninIBA 01/2019
1	Therapeutic UsesIBA 07/2018
1	Dopamine (Intropin)FDA LinkGeneric 01/2018
1	valylvaline (Val-Val)IBA 01/2018
1	ChitinasesIBA 01/2017
1	Natalizumab (Tysabri)FDA Link 01/2017
1	Glial Fibrillary Acidic ProteinIBA 04/2016
1	Glutamic Acid (Glutamate)FDA Link 03/2016
1	Glutamine (L-Glutamine)FDA Link 03/2016

Therapy/Procedure

2	Therapeutics 01/2019 - 07/2003
2	Catheters 01/2008 - 04/2007
2	Aftercare (After-Treatment) 11/2001 - 03/2001
1	Radiotherapy 04/2018
1	Cranial Irradiation 04/2018